NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT [Corrigendum]

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s239515
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Fibronectin 1 Promotes Migration and Invasion of Papillary Thyroid Cancer and Predicts Papillary Thyroid Cancer Lymph Node Metastasis

OncoTargets and Therapy
OncologyPharmacology
2017English

miR-29a Inhibits Proliferation, Invasion, and Migration of Papillary Thyroid Cancer by Targeting DPP4

OncoTargets and Therapy
OncologyPharmacology
2019English

HSPC159 Promotes Proliferation and Metastasis via Inducing EMT and Activating PI3K/Akt Pathway in Breast Cancer

Cancer Science
Cancer ResearchMedicineOncology
2018English

MicroRNA‑744 Suppresses Cell Proliferation and Invasion of Papillary Thyroid Cancer by Directly Targeting NOB1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

miR-96 Promotes Cell Proliferation, Migration and Invasion by Targeting PTPN9 in Breast Cancer

Scientific Reports
Multidisciplinary
2016English

Knockdown of ACTA2‑AS1 Promotes Liver Cancer Cell Proliferation, Migration and Invasion

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

The HOTAIRM1/miR-107/TDG Axis Regulates Papillary Thyroid Cancer Cell Proliferation and Invasion

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Correction: CLCA4 Inhibits Bladder Cancer Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/AKT Pathway

Oncotarget
Oncology
2019English

miRNA‑222 Promotes Liver Cancer Cell Proliferation, Migration and Invasion and Inhibits Apoptosis by Targeting BBC3

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy